Vienna Institute for Research in Ocular Surgery
66
4
8
30
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.1%
4 terminated/withdrawn out of 66 trials
88.2%
+1.7% vs industry average
5%
3 trials in Phase 3/4
0%
0 of 30 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (66)
Peeling of the Internal Limiting Membrane During Primary Vitrectomy for Retinal Detachment Repair
Role: lead
Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Role: lead
Eyelid Closure in Keratometry
Role: lead
Visual Function of Enhanced Monofocal Intraocular Lenses
Role: lead
Capsule Bag Performance of a Novel Single-piece Acrylic IOL HOYA AF-1 NY-60
Role: lead
Role of Metformin in Posterior Capsule Opacification
Role: lead
Computer-based Tutorial as a Means to Enhance the Informed Consent Process for Cataract Surgery
Role: lead
Brillouin Microscopy Used to Evaluate Corneal Mechanical Properties
Role: lead
Detection of Keratoconus Progression Using Machine Learning
Role: lead
Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition
Role: lead
Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses
Role: lead
Role of Postoperative Lubrication in Cataract Surgery
Role: lead
Cultivation of Hyalocytes From ILM and ERM Samples: a Pilot Study
Role: lead
iOCT for Patients With Diabetic Macular Edema
Role: lead
Caffeine and Cataract After Pars Plana Vitrectomy
Role: lead
Comparison of Two Non-diffractive Enhanced Monofocal Intraocular Lenses
Role: lead
Stability of Secondary Intraocular Lenses With no Capsular Support
Role: lead
Visual Acuity and Optical Coherence Tomography One Year After Peeling of Epiretinal Membranes
Role: lead
Foveal Sparing ILM Peeling With ILM Flap Transposition
Role: lead
Deep Learning Assisted Epithelial Basement Membrane Dystrophy Detection
Role: lead